Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII

Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained uncle...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 101; no. 4; pp. 427 - 436
Main Authors Mattheij, Nadine J A, Swieringa, Frauke, Mastenbroek, Tom G, Berny-Lang, Michelle A, May, Frauke, Baaten, Constance C F M J, van der Meijden, Paola E J, Henskens, Yvonne M C, Beckers, Erik A M, Suylen, Dennis P L, Nolte, Marc W, Hackeng, Tilman M, McCarty, Owen J T, Heemskerk, Johan W M, Cosemans, Judith M E M
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.04.2016
Subjects
Online AccessGet full text
ISSN1592-8721
0390-6078
1592-8721
DOI10.3324/haematol.2015.131441

Cover

Abstract Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3.
AbstractList Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3.Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3.
Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α(IIb)β3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α(IIb)β3 Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α(IIb)β3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in α(IIb)β3(Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α(IIb)β3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α(IIb)β3.
Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin α IIb β 3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin α IIb β 3 . Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin α IIb β 3 . Vice versa , star-like fibrin formation from platelets of a patient with deficiency in α IIb β 3 (Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial α IIb β 3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin α IIb β 3 .
Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular proteins; ii) by exposure of procoagulant phosphatidylserine; or iii) by high fibrinogen binding. Yet, their functional role has remained unclear. Here we used a novel transglutaminase probe, Rhod-A14, to identify a subpopulation of platelets with a cross-linked protein coat, and compared this with other platelet subpopulations using a panel of functional assays. Platelet stimulation with convulxin/thrombin resulted in initial integrin αIIbβ3 activation, the appearance of a platelet population with high fibrinogen binding, (independently of active integrins, but dependent on the presence of thrombin) followed by phosphatidylserine exposure and binding of coagulation factors Va and Xa. A subpopulation of phosphatidylserine-exposing platelets bound Rhod-A14 both in suspension and in thrombi generated on a collagen surface. In suspension, high fibrinogen and Rhod-A14 binding were antagonized by combined inhibition of transglutaminase activity and integrin αIIbβ3. Markedly, in thrombi from mice deficient in transglutaminase factor XIII, platelet-driven fibrin formation and Rhod-A14 binding were abolished by blockage of integrin αIIbβ3. Vice versa, star-like fibrin formation from platelets of a patient with deficiency in αIIbβ3 (Glanzmann thrombasthenia) was abolished upon blockage of transglutaminase activity. We conclude that coated platelets, with initial αIIbβ3 activation and high fibrinogen binding, form a subpopulation of phosphatidylserine-exposing platelets, and function in platelet-dependent star-like fibrin fiber formation via transglutaminase factor XIII and integrin αIIbβ3.
Author Mattheij, Nadine J A
Cosemans, Judith M E M
Suylen, Dennis P L
Swieringa, Frauke
McCarty, Owen J T
May, Frauke
Nolte, Marc W
Mastenbroek, Tom G
Berny-Lang, Michelle A
Heemskerk, Johan W M
Baaten, Constance C F M J
van der Meijden, Paola E J
Henskens, Yvonne M C
Hackeng, Tilman M
Beckers, Erik A M
AuthorAffiliation 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
4 Central Diagnostic Laboratory, Maastricht University Medical Center, The Netherlands
3 CSL Behring GmbH, Marburg, Germany
2 Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA
5 Department of Internal Medicine, Maastricht University Medical Center, The Netherlands
AuthorAffiliation_xml – name: 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– name: 5 Department of Internal Medicine, Maastricht University Medical Center, The Netherlands
– name: 4 Central Diagnostic Laboratory, Maastricht University Medical Center, The Netherlands
– name: 3 CSL Behring GmbH, Marburg, Germany
– name: 2 Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA
Author_xml – sequence: 1
  givenname: Nadine J A
  surname: Mattheij
  fullname: Mattheij, Nadine J A
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 2
  givenname: Frauke
  surname: Swieringa
  fullname: Swieringa, Frauke
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 3
  givenname: Tom G
  surname: Mastenbroek
  fullname: Mastenbroek, Tom G
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 4
  givenname: Michelle A
  surname: Berny-Lang
  fullname: Berny-Lang, Michelle A
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA
– sequence: 5
  givenname: Frauke
  surname: May
  fullname: May, Frauke
  organization: CSL Behring GmbH, Marburg, Germany
– sequence: 6
  givenname: Constance C F M J
  surname: Baaten
  fullname: Baaten, Constance C F M J
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 7
  givenname: Paola E J
  surname: van der Meijden
  fullname: van der Meijden, Paola E J
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 8
  givenname: Yvonne M C
  surname: Henskens
  fullname: Henskens, Yvonne M C
  organization: Central Diagnostic Laboratory, Maastricht University Medical Center, The Netherlands
– sequence: 9
  givenname: Erik A M
  surname: Beckers
  fullname: Beckers, Erik A M
  organization: Department of Internal Medicine, Maastricht University Medical Center, The Netherlands
– sequence: 10
  givenname: Dennis P L
  surname: Suylen
  fullname: Suylen, Dennis P L
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 11
  givenname: Marc W
  surname: Nolte
  fullname: Nolte, Marc W
  organization: CSL Behring GmbH, Marburg, Germany
– sequence: 12
  givenname: Tilman M
  surname: Hackeng
  fullname: Hackeng, Tilman M
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 13
  givenname: Owen J T
  surname: McCarty
  fullname: McCarty, Owen J T
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA
– sequence: 14
  givenname: Johan W M
  surname: Heemskerk
  fullname: Heemskerk, Johan W M
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
– sequence: 15
  givenname: Judith M E M
  surname: Cosemans
  fullname: Cosemans, Judith M E M
  email: judith.cosemans@maastrichtuniversity.nl
  organization: Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands judith.cosemans@maastrichtuniversity.nl
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26721892$$D View this record in MEDLINE/PubMed
BookMark eNpVkctqFUEQhhuJmIu-gcgs3cyxrzPTG0EORgcCbhTcDdW3kw493ceengQfSx8kz5Q-JoZkVcVfP99PVZ2io5iiRegtwRvGKP9wCXaGksKGYiI2hBHOyQt0QoSk7dBTcvSkP0any3KFMcVS9q_QMe2qOEh6gm62CYo1zT7UEmxZGrdGXXyKjY-Pamvs3kZjY2mcV7lOXMo1_WC79lCtxe4O8u2fcVS3f1kD0TQlQ1x2YS0w-wiLbRzoknLzcxzH1-ilg7DYNw_1DP04__x9-7W9-PZl3H66aE1dsrSql9yBxIbqoddakV4ZpaSRjGgrGSNGd1RqLhQBQZ2FToAA4zhgoNwpdobGe65JcDXts58h_54S-OmfkPJugly8DnYCdrgJF0b0HVfYDKC4YtZSNTDqsKysj_es_apma3Q9R4bwDPp8Ev3ltEvXk8CYM0kq4P0DIKdfq13KNPtF2xAg2rQuE-n7Xg60Y6Ja3z3Negz5_zl2B0mepAs
ContentType Journal Article
Copyright Copyright© Ferrata Storti Foundation.
Copyright© Ferrata Storti Foundation 2016
Copyright_xml – notice: Copyright© Ferrata Storti Foundation.
– notice: Copyright© Ferrata Storti Foundation 2016
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3324/haematol.2015.131441
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1592-8721
EndPage 436
ExternalDocumentID oai_doaj_org_article_a3218945d5764b0d8ab4b3ee2b832f09
PMC5004391
26721892
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01HL101972
– fundername: NHLBI NIH HHS
  grantid: R01 HL101972
GroupedDBID ---
29I
2WC
53G
5GY
5RE
5VS
AAFWJ
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
C1A
CGR
CS3
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GROUPED_DOAJ
H13
HYE
KQ8
M~E
NPM
OK1
P2P
RHF
RHI
RNS
RPM
SJN
SV3
TFS
TR2
UDS
W8F
WOQ
WOW
7X8
AFPKN
OVT
5PM
ID FETCH-LOGICAL-d332t-b794fa90d2c87ccb17bdbb9d931ce9331dc629c45b1a52fea65a5adf4a0a24fb3
IEDL.DBID DOA
ISSN 1592-8721
0390-6078
IngestDate Wed Aug 27 01:30:36 EDT 2025
Thu Aug 21 18:08:21 EDT 2025
Thu Jul 10 22:57:06 EDT 2025
Thu Jan 02 22:22:18 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License Copyright© Ferrata Storti Foundation.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d332t-b794fa90d2c87ccb17bdbb9d931ce9331dc629c45b1a52fea65a5adf4a0a24fb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
FS and TGM contributed equally to this work
OpenAccessLink https://doaj.org/article/a3218945d5764b0d8ab4b3ee2b832f09
PMID 26721892
PQID 1777982635
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_a3218945d5764b0d8ab4b3ee2b832f09
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5004391
proquest_miscellaneous_1777982635
pubmed_primary_26721892
PublicationCentury 2000
PublicationDate 2016-04-01
PublicationDateYYYYMMDD 2016-04-01
PublicationDate_xml – month: 04
  year: 2016
  text: 2016-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Italy
PublicationPlace_xml – name: Italy
PublicationTitle Haematologica (Roma)
PublicationTitleAlternate Haematologica
PublicationYear 2016
Publisher Ferrata Storti Foundation
Publisher_xml – name: Ferrata Storti Foundation
References 11805836 - Nature. 2002 Jan 10;415(6868):175-9
25027852 - Nat Commun. 2014 Jul 16;5:4257
12529747 - Thromb Haemost. 2002 Dec;88(6):967-74
25331118 - Blood. 2014 Dec 18;124(26):3982-90
19967145 - Thromb Haemost. 2009 Dec;102(6):1149-56
26149024 - J Thromb Haemost. 2015 Jun;13 Suppl 1:S2-9
24336148 - J Head Trauma Rehabil. 2014 Nov-Dec;29(6):522-6
16105983 - Blood. 2005 Dec 15;106(13):4146-51
22502645 - Platelets. 2012;23(3):229-42
23149559 - J Cereb Blood Flow Metab. 2013 Feb;33(2):287-92
23519467 - J Biol Chem. 2013 May 10;288(19):13325-36
15341700 - Curr Hematol Rep. 2004 Sep;3(5):338-43
15010476 - J Biol Chem. 2004 May 7;279(19):19854-9
16241952 - J Thromb Haemost. 2005 Nov;3(11):2545-53
12351391 - Blood. 2002 Oct 15;100(8):2827-31
11816711 - Thromb Haemost. 2001 Nov;86(5):1221-8
25184360 - Stroke. 2014 Oct;45(10):2995-3001
12853707 - Pathophysiol Haemost Thromb. 2003;33(1):4-15
11313254 - Blood. 2001 May 1;97(9):2648-56
25205226 - Mol Cell Proteomics. 2014 Dec;13(12):3435-45
2866189 - J Biol Chem. 1985 Dec 15;260(29):16012-20
20519511 - J Biol Chem. 2010 Jul 30;285(31):23629-38
16194197 - J Thromb Haemost. 2005 Oct;3(10):2185-92
23667186 - Cardiovasc Res. 2013 Jul 15;99(2):342-52
15131115 - J Biol Chem. 2004 Jul 16;279(29):30697-706
24338009 - J Biol Chem. 2014 Jan 24;289(4):2371-83
17082321 - Blood. 2007 Mar 1;109 (5):1931-7
22669259 - Cell Mol Life Sci. 2012 Oct;69(20):3481-92
16840732 - Blood. 2006 Nov 1;108(9):3045-52
21037087 - Blood. 2011 Jan 13;117(2):651-60
20479008 - J Biol Chem. 2010 Jul 23;285(30):23410-9
22869793 - Blood. 2012 Oct 11;120(15):e73-82
24443567 - J Biol Chem. 2014 Mar 7;289(10):6526-34
23303912 - Physiol Rev. 2013 Jan;93(1):327-58
23995838 - J Biol Chem. 2013 Oct 11;288(41):29621-32
23106920 - J Thromb Haemost. 2013 Jan;11(1):2-16
18757293 - Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2023-9
19679287 - JACC Cardiovasc Imaging. 2009 Aug;2(8):987-96
References_xml – reference: 23149559 - J Cereb Blood Flow Metab. 2013 Feb;33(2):287-92
– reference: 12529747 - Thromb Haemost. 2002 Dec;88(6):967-74
– reference: 16241952 - J Thromb Haemost. 2005 Nov;3(11):2545-53
– reference: 20519511 - J Biol Chem. 2010 Jul 30;285(31):23629-38
– reference: 21037087 - Blood. 2011 Jan 13;117(2):651-60
– reference: 23995838 - J Biol Chem. 2013 Oct 11;288(41):29621-32
– reference: 24336148 - J Head Trauma Rehabil. 2014 Nov-Dec;29(6):522-6
– reference: 22869793 - Blood. 2012 Oct 11;120(15):e73-82
– reference: 25331118 - Blood. 2014 Dec 18;124(26):3982-90
– reference: 2866189 - J Biol Chem. 1985 Dec 15;260(29):16012-20
– reference: 15010476 - J Biol Chem. 2004 May 7;279(19):19854-9
– reference: 11816711 - Thromb Haemost. 2001 Nov;86(5):1221-8
– reference: 15131115 - J Biol Chem. 2004 Jul 16;279(29):30697-706
– reference: 25027852 - Nat Commun. 2014 Jul 16;5:4257
– reference: 23303912 - Physiol Rev. 2013 Jan;93(1):327-58
– reference: 12853707 - Pathophysiol Haemost Thromb. 2003;33(1):4-15
– reference: 23519467 - J Biol Chem. 2013 May 10;288(19):13325-36
– reference: 12351391 - Blood. 2002 Oct 15;100(8):2827-31
– reference: 16840732 - Blood. 2006 Nov 1;108(9):3045-52
– reference: 23667186 - Cardiovasc Res. 2013 Jul 15;99(2):342-52
– reference: 19679287 - JACC Cardiovasc Imaging. 2009 Aug;2(8):987-96
– reference: 22502645 - Platelets. 2012;23(3):229-42
– reference: 19967145 - Thromb Haemost. 2009 Dec;102(6):1149-56
– reference: 23106920 - J Thromb Haemost. 2013 Jan;11(1):2-16
– reference: 18757293 - Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):2023-9
– reference: 16194197 - J Thromb Haemost. 2005 Oct;3(10):2185-92
– reference: 25184360 - Stroke. 2014 Oct;45(10):2995-3001
– reference: 20479008 - J Biol Chem. 2010 Jul 23;285(30):23410-9
– reference: 26149024 - J Thromb Haemost. 2015 Jun;13 Suppl 1:S2-9
– reference: 25205226 - Mol Cell Proteomics. 2014 Dec;13(12):3435-45
– reference: 16105983 - Blood. 2005 Dec 15;106(13):4146-51
– reference: 11805836 - Nature. 2002 Jan 10;415(6868):175-9
– reference: 15341700 - Curr Hematol Rep. 2004 Sep;3(5):338-43
– reference: 22669259 - Cell Mol Life Sci. 2012 Oct;69(20):3481-92
– reference: 24443567 - J Biol Chem. 2014 Mar 7;289(10):6526-34
– reference: 17082321 - Blood. 2007 Mar 1;109 (5):1931-7
– reference: 11313254 - Blood. 2001 May 1;97(9):2648-56
– reference: 24338009 - J Biol Chem. 2014 Jan 24;289(4):2371-83
SSID ssj0020997
Score 2.4077702
Snippet Coated platelets, formed by collagen and thrombin activation, have been characterized in different ways: i) by the formation of a protein coat of α-granular...
SourceID doaj
pubmedcentral
proquest
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 427
SubjectTerms Animals
Blood Coagulation
Blood Platelets - drug effects
Blood Platelets - metabolism
Blood Platelets - pathology
Crotalid Venoms - pharmacology
Factor Va - chemistry
Factor Va - metabolism
Factor Xa - chemistry
Factor Xa - metabolism
Factor XIII - chemistry
Factor XIII - metabolism
Fibrin - chemistry
Fibrin - metabolism
Fibrinogen - chemistry
Fibrinogen - metabolism
Humans
Lectins, C-Type
Mice
Mice, Knockout
Molecular Probes - chemistry
Phosphatidylserines - chemistry
Phosphatidylserines - metabolism
Platelet Activation - drug effects
Platelet Glycoprotein GPIIb-IIIa Complex - chemistry
Platelet Glycoprotein GPIIb-IIIa Complex - metabolism
Primary Cell Culture
Protein Binding
Thrombasthenia - blood
Thrombasthenia - pathology
Thrombin - pharmacology
Title Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII
URI https://www.ncbi.nlm.nih.gov/pubmed/26721892
https://www.proquest.com/docview/1777982635
https://pubmed.ncbi.nlm.nih.gov/PMC5004391
https://doaj.org/article/a3218945d5764b0d8ab4b3ee2b832f09
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEG4kB_EimvhYH6EF8TZm-jU9fUxCQkaIJwN7G_ppFrQ3uBPFn6U_JL8pVdOzS1YEL54GemC66K-aqpqq-oqQt4Y3ykvHsHoKAhQWVNVK5isd0aAHr5txdML5x-bsQn6Yq_mdUV9YE1bogcvBHVgBRshIFcAxlq4OrXXSiRi5A11MpXWvNvU6mJpCLewHHfMHBoIjsIKlaU6A93BwaZEMdYlpB6beM4ERxUTY_zcv889iyTvW5_QReTi5jfSwiPuY3It5l-wdZtji60_6jo6FnOMf8l1y_3zKl--RH8dL8CUDvfoCD0BoRdGOIRZ0kTer1XoS7kATdgBkumlppN8XlhZKCVi--dV17ua3oDYHOqCV-wyKa7GaZhVpGd1D513XPSEXpyefjs-qadRCFeBQhsrBtUzW1IH7VnvvmHbBOROMYD4aIVjwDTdeKses4inaRlllQ5K2tlwmJ56SnbzM8TmhzqWgkBXMRy8lt1bzZHRsnfNKqcRn5AjPur8qbBo98luPC4B6P6He_wv1GXmzRqqH-4BJDpvj8nrVM621aZFiZ0aeFeQ2W_FG42dBBL2F6ZYs22_y4nLk3FaYMjXsxf8Q_iV5ALrXlPqfV2Rn-HYdX4NrM7j9UYtvAXkG-ts
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coated+platelets+function+in+platelet-dependent+fibrin+formation+via+integrin+%CE%B1IIb%CE%B23+and+transglutaminase+factor+XIII&rft.jtitle=Haematologica+%28Roma%29&rft.au=Mattheij%2C+Nadine+J+A&rft.au=Swieringa%2C+Frauke&rft.au=Mastenbroek%2C+Tom+G&rft.au=Berny-Lang%2C+Michelle+A&rft.date=2016-04-01&rft.eissn=1592-8721&rft.volume=101&rft.issue=4&rft.spage=427&rft_id=info:doi/10.3324%2Fhaematol.2015.131441&rft_id=info%3Apmid%2F26721892&rft.externalDocID=26721892
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1592-8721&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1592-8721&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1592-8721&client=summon